Atlas Trials

Study of Switching to Aflibercept 8 mg in Patients With Refractory or Dependent Exudative Age-related Macular Degeneration

Clinical trial NCT07423429 · RECRUITING

Trial details

NCT number
NCT07423429
Sponsor
Nantes University Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Exudative Age-Related Macular Degeneration
Start date
2026-02-20
Primary completion
2026-10-20
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.